Treatments of coronary artery disease (CAD)/coronary heart disease (CHD) are associated with various complications or adverse effects. Briefly these include:1
angiotensin-converting enzyme inhibitors (ACEIs): dry cough, dizziness and fainting
angiotensin-receptor blockers (ARBs): mild dizziness
antiplatelet agents: aspirin has been associated with bleeding risk particularly in patients with an underlying hemostatic defect (e.g. hemophilia, uremia) and gastrointestinal toxicity. For further information on guidelines on antiplatelet therapies please see Antiplatelet Drugs2
Please note: For further details of complications associated with specific CAD therapies please refer to individual summary of product characteristics.
NHS choices website, Coronary heart disease – Treatment. Accessed 28 February 2011.
Patrono C, Baigent C, Hirsh J, Roth G; American College of Chest Physicians. Antiplatelet Drugs American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:199S–233S.